| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |